Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Immunol Regen Med. 2018 Apr 25;1:57–66. doi: 10.1016/j.regen.2018.03.004

Figure 3.

Figure 3

Mean intensity of indirect immunofluorescent antibody staining of macrophages treated with ECM degradation products for F4/80 (A), iNOS (B), Arginase-1 (C), Fizz1 (D), CCR2 (E), and CX3CR1 (F). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001